longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DataMeds AI

MEDS

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: DataMeds AI(MEDS) the Revenue is 1.78 M (-77.15%);the EBIT is -7.345 M (-33.54%);the EPS is -7.13 (-32.06%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B77.15%
----
----
EBIT
-0.01B33.54%
----
----
EPS
-7.132332.06%
----
----

Revenue

ActualEstimateUnit: USD
qf

EBIT

ActualEstimateUnit: USD
qf

Net income

ActualEstimateUnit: USD
qf

EPS

ActualEstimateUnit: USD
qf